Smith & Nephew plc's receivables is $1.5B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), SNN shows a receivables of $1.5B. That compares with $1.5B in the prior-year period — up 0.3% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SNN's receivables is now $1.5B (was $1.5B) — a 0.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Smith & Nephew plc is outperforming or lagging.
Tracking SNN's receivables over time shows whether Smith & Nephew plc is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5B That compares with $1.5B in the prior-year period — up 0.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this receivables page, Stockcircle has Smith & Nephew plc's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.5B) with ownership activity and broader fundamentals.
Smith & Nephew plc's receivables is $1.5B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.